From Alchemy to IPO – The Business of Biotechnology

kettleitchyBiotechnology

Dec 5, 2012 (4 years and 6 months ago)

175 views

Overview


Industry Overview


Impacted Industries


Science


Business Issues


Examples


Where do you fit?


Getting Involved


Websites


Other Resources

Statistics


Impact of Biotechnology

Nutrition

Human

Health

Crop

Production

Industrial

Products

Slide courtesy of Dick Kouri

The Business of Biotechnology

Industrial

Applications



Enzymes



Chemicals



Fiber



Fermentation

Crop

Production



Seeds



Chemicals



Fertilizers



Outputs

Nutrition



Food



Animal feeds

Databases



Pharmaceuticals



Agriculture



Other

$0.5 B

$135 B

$500 B

$800 B

High Barriers

Low Margins

High Barriers

Low Margins

Low

-

High

Barriers

Low

-

Med

Margins

Low Barriers

High Margins

Human

Health



Pharmaceutical



Nutraceuticals



Botanicals



Additives

$450 B

Low

-

High

Barriers

Med

-

High

Margins

Slide courtesy of Dick Kouri


$500 billion market


New products: additives,
botanicals, foods, and health
foods that will improve nutrition


Food Companies
-

$300B in
Sales for the Top 30 Companies


Additives
-

$4
-
8 B (Dominated
by Roche)


Growing Markets


Health Foods
-

$100 B


Botanicals


$0.5 B



Nutrition

Slide courtesy of Dick Kouri

Crop Production


$786 billion market


New products: herbicides,
fungicides, fertilizers, seeds, and
crop outputs that are high value
and environmentally friendly


Major Players


Monsanto


Bayer (Office in RTP)


Novartis


Syngenta


Local Companies


Paradigm Genetics


Crop Solutions

Slide courtesy of Dick Kouri

Industrial Products


$135 billion market


New products:

fibers, industrial enzymes,
specialty chemicals, paper
and pulp for new and
improved processes

Human Health


$400 billion market


New products:

antibiotics, diagnostics,
vaccines, nutraceuticals, and
pharmaceuticals for disease
prevention

and treatment


Major Players: All Big Pharma


Local Companies


See NC Biotech website



Science


Basics


Cell


DNA
-
RNA
-
protein


Applications


Genomics


Gene Therapies


Proteomics


Activating process


Monoclonal Antibodies


Business Issues


Time and funding


Small molecules vs. molecule and
problems


Pills vs. Injection


Manufacturing


Complicated


can’t make enough


Examples


Top drugs


Amgen



Small Companies


AlphaVax


Where do MBAs fit in?


Business Development


Business Plan Writing


Licensing and Partnerships


Marketing and Sales


Big Pharma


Marketing Strategy
-
> Developing Partnerships


Market Research


Market Sizing


Competitive Intelligence


Sales Rotations


Finance


Investor relations


Funding strategies for start
-
ups


Corporate finance for larger firms

How to Get Involved


CED


www.cednc.org


Volunteer for events through e
-
club


Biotech Forum


2
nd

Monday


Biotech Club Events


VCIC Competition


Entrepreneurship Club Speaker Series

Websites


Biotech Club website


List of applicable sites


NC Biotech Center


www.ncbiotech.org


Other Resources


Brookings Institution Report


www.brook.edu/dybdocroot/es/urban/publications/biotech.p
df


PHRMA Report on New Medicine Development for Biotech


www.phrma.org/newmedicines/resources/2002
-
10
-
21.93.pdf


S&P 500 Industry Overview


OCS Library


From Alchemy to IPO


The Business of Biotechnology

by
Cynthia Robbins
-
Roth


The Million Dollar Molecule

by